跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TOPIRAMATE-LAPL topiramate 50 mg tablet blister - TGA Drug Approval Details
Approvals
/
TGA
/
TOPIRAMATE-LAPL topiramate 50 mg tablet blister
Approved
STANDARD
TOPIRAMATE-LAPL topiramate 50 mg tablet blister
Lupin Australia Pty Limited
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
42c0d95d013cf216
Company
Lupin Australia Pty Limited
Type
Standard
Approval Details
Approval Id
42c0d95d013cf216
Product Name
TOPIRAMATE-LAPL topiramate 50 mg tablet blister
Artg Id
155193
Artg Name
TOPIRAMATE-LAPL topiramate 50 mg tablet blister
Sponsor
Lupin Australia Pty Limited
Company Detail Path
/organization/lupin-australia-pty-limited
Artg Date
2010-04-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
42c0d95d013cf216
Type
Standard
Back to TGA Approvals
